Commercialization: Page 82
-
PharmaVoice Team/PharmaVoice
Global Thought leaders
Karla Anderson, Managing Director, Life Sciences, BearingPoint Inc. — A provider of management and technology consulting services. For more information, visit bearingpoint.com. Leone Atkinson, M.D., Senior Director of Clinical Development, PTC Therapeutics Inc. — A biopharmaceutical company focus...
By PharmaVoice Team • Feb. 27, 2009 -
PharmaVoice Team/PharmaVoice
Mobile Marketing
by Robin Robinson Experts anticipate that mobile marketing is going to contribute significantly to the pharmaceutical marketing mix in the future. From text messages to videos, smart phones can be used to help educate and mentor a patient to be more compliant and adherent and create better relati...
By Robin Robinson • Feb. 27, 2009 -
PharmaVoice Team/PharmaVoice
GLOBAL Marketing Trends Communication Around Risk Management
Proactive communications around risk management is a new critical success factor for life-cycle management. Ilyssa Levins • The Center for Communication Compliance Everyone needs to be accountable for regulatory compliance, including communication agencies, which can no longer abdicate responsibi...
By PharmaVoice Team • Feb. 27, 2009 -
PharmaVoice Team/PharmaVoice
Myth or Fact? GLOBAL Branding
by Robin Robinson Brand development has gone global, while execution, for the most part, remains local. While marketers have developed effective strategies and executions to create successful multinational campaigns, what constitutes a global brand remains up for debate. “Creating global position...
By Robin Robinson • Feb. 27, 2009 -
PharmaVoice Team/PharmaVoice
GLOBAL Development
BY DENISE MYSHKO Drug developers are looking to emerging markets and increasing their outsourcing efforts as ways to access expertise and reach. Pharmaceutical companies will continue to globalize their preclinical and clinical development activities to increase speed-to-market and expand their p...
By PharmaVoice Team • Feb. 26, 2009 -
PharmaVoice Team/PharmaVoice
GLOBAL Talent
As companies globalize and seek to maximize the opportunities and challenges that result, they need to ensure that they have an understanding of the talent potential that exists globally. All too often companies think in local operating terms or seek to attract talent within the country where the...
By PharmaVoice Team • Feb. 26, 2009 -
PharmaVoice Team/PharmaVoice
Buying Big GLOBAL
How M&A Impacts the Pharma Market As patent expirations and dwindling pipelines, along with an embattled economy, put a dent on pharma profits, acquisitions again become a necessity for large pharma companies seeking to maintain a healthy bottom line. With Pfizer’s purchase of Wyeth, among ot...
By PharmaVoice Team • Feb. 26, 2009 -
PharmaVoice Team/PharmaVoice
Going... Going... GLOBAL
by Robin Robinson Companies are exploring new business opportunities and models to better manage operations located around the world. Fred Hassan • Schering-Plough We’ve been working very hard to develop our global culture, and by that I mean the way people can expect to work with each other — or...
By Robin Robinson • Feb. 26, 2009 -
PharmaVoice Team/PharmaVoice
Talent Pool
Pharmaceutical POOL Deirdre CONNELLY GlaxoSmithKline Selects Head of North American Pharma Business Deirdre Connelly, former president of U.S. operations at Eli Lilly, has joined GlaxoSmithKline (GSK) as president, North American pharmaceuticals. Ms. Connelly was appointed president of U.S. opera...
By PharmaVoice Team • Feb. 26, 2009 -
PharmaVoice Team/PharmaVoice
PharmaTrax
Sales, marketing, And R&D Trends affectinga the healthcare industry EU Candidate Countries Offer Ripe Field for Clinical-Trial Recruitment Conducting clinical trials in Europe is not a new concept for global pharmaceutical companies, but choosing the country in which to hold a particular tria...
By PharmaVoice Team • Feb. 26, 2009 -
PharmaVoice Team/PharmaVoice
PharmaOutlet
Contributed by Ken Begasse Jr. The Changing sales model provides greater value for customers Over the past few years, the practice of healthcare has changed significantly, forcing marketers to reevaluate their strategies, tools, and tactics. One change has been to reverse the previous trend towar...
By Ken Begasse Jr. • Feb. 26, 2009 -
PharmaVoice Team/PharmaVoice
Upfront
Milestones kinetix turns 10 Kinetix, a specialized healthcare consulting firm that uses exclusive, proprietary communication channels to build and implement live and online marketing programs, is celebrating its 10th anniversary. Over the last 10 years, Kinetix has developed strategies to communi...
By PharmaVoice Team • Feb. 26, 2009 -
PharmaVoice Team/PharmaVoice
Raise Your Voice
A winter of discontent Oh, yes, change is in the air. Alan Greenspan is humbled before a congressional committee, forced to admit that perhaps, just perhaps, his faith in the market was misplaced. If this paragon of libertarianism finds himself nonplussed, it is no surprise that lesser lights amo...
By PharmaVoice Team • Feb. 26, 2009 -
PharmaVoice Team/PharmaVoice
Letter from the Editor
Global is as global does A New World Order Welcome to the first annual Going Global special issue. We recognize that spanning the globe like Jim McKay is no easy feat and impossible to do in one publication, but we hope to avoid the agony of defeat as we bring you a sampling of the trends and eve...
By Taren Grom • Feb. 26, 2009 -
PharmaVoice Team/PharmaVoice
Venture Capital: Funding Challenges
VENTURE CAPITAL: CAUTIOUS investment Venture capital firms are sitting on massive funds and are still doing deals, but their energies are focused on reinvesting in portfolio companies and safer latest age deals. As a result, it has never been harder for the early stage pure startup to get funded....
By PharmaVoice Team • Feb. 23, 2009 -
PharmaVoice Team/PharmaVoice
A Community Approach
As many pharmaceutical companies are finding, healthcare begins within the community, and a regional program, with health information that helps patients at a local level, might just win a company the hearts, minds, and ultimately buying power of those community members. For an industry confronte...
By PharmaVoice Team • Feb. 23, 2009 -
PharmaVoice Team/PharmaVoice
Delivering on the Promise
BY ELISABETH PENA Drug delivery promises FULLER PIPELINES, EXTENDED PRODUCT LIFE CYCLES, and IMPROVED PATIENT COMPLIANCE. AS THE PHARMACEUTICAL INDUSTRY FACES A FLOOD OF BLOCKBUSTER DRUG PATENT EXPIRATIONS, drug-delivery COMPANIES WILL HAVE THE CHANCE TO PROVE THEMSELVES. BY 2005 analysts predict...
By PharmaVoice Team • Feb. 23, 2009 -
PharmaVoice Team/PharmaVoice
PharmaTrax
SALES, MARKETING, AND R&D TRENDS AFFECTING THE HEALTHCARE INDUSTRY GENERICS SECTOR Expected to Double by 2007 According to Datamonitor, by 2007 the generics market is expected to be valued at $57 billion, more than twice its estimated value of $27 billion in 2001. Researchers at the company c...
By PharmaVoice Team • Feb. 22, 2009 -
PharmaVoice Team/PharmaVoice
For Art's Sake
There are a handful of “classic” pharmaceutical healthcare ads. Ads that stand the test of time and follow the basic tenets of good advertising. Once again, Abelson-Taylor’s ad campaign for Hytrin has been identified as such a classic. According to Don Martiny, the Hytrin Balloon campaign, which ...
By PharmaVoice Team • Feb. 22, 2009 -
PharmaVoice Team/PharmaVoice
PharmaOutlet
A WHOLE NEW MEANING TO JUNK MAIL If you are depressed that the only things you seem to receive in the mail are bills, there may be a cure. Last summer, some sales representatives in southern Florida allegedly orchestrated a promotional scheme, with the cooperation of one or more physician practic...
By Brian P. Waldman • Feb. 22, 2009 -
PharmaVoice Team/PharmaVoice
PharmaCase
Making a case for PATIENT EDUCATION Patient ed project puts pharma company on ‘Write track’ with cancer patients EVER CONSIDER PITCHING YOUR BOSS ON A LARGE-SCALE PATIENT EDUCATION PROJECT THAT: A.) WOULD BE VERY EXPENSIVE, B.) WOULD NOT DIRECTLY SUPPORT ANY OF YOUR PRODUCTS, AND C.) WOULD DEFY A...
By PharmaVoice Team • Feb. 22, 2009 -
PharmaVoice Team/PharmaVoice
What's on your mind: Opinions
OPINIONS Information standards In the November/December issue of PharmaVOICE, we asked if the Food and Drug Administration should consider relaxing its standards for press releases about drug approvals, which currently are almost always considered a promotion. The regulatory agency issued a call ...
By PharmaVoice Team • Feb. 22, 2009 -
PharmaVoice Team/PharmaVoice
Raise Your Voice: Letters
LETTERS Two critical areas of success Missed Opportunities Your article on “The Patient Pipeline” highlighted many of the difficulties in patient accrual and retention. Unfortunately the solutions in my opinion missed two critical success factors. As CEO and cofounder of MCSI, the largest U.S.-b...
By PharmaVoice Team • Feb. 22, 2009 -
PharmaVoice Team/PharmaVoice
Letter from the Editor
Funding in a closed space The healthcare private equity market was down in 2002, and industry experts don’t expect a gr eat deal of improvement in 2003. Venture capital firms are sit ting on massive funds and are still doing deals, but according to Russell LaMontagne, president and founder of Cor...
By Taren Grom • Feb. 22, 2009 -
PharmaVoice Team/PharmaVoice
Information Technology: Tracking the E-Volution
Pharmaceutical companies have long term plans, they have products that take a long time to develop, a long time to test to gain approval, and they have a shelf life. But technology moves so much faster than that. So the industry as a whole has had to adopt to the speed of technology. IAN CROSS BY...
By PharmaVoice Team • Feb. 21, 2009
Previous
